| The vaccine and dosing schedule | Who needs it? | Severe consequences of natural disease |
Moderate or severe vaccine side effects (%) | Vaccine efficacy (%) |
| Chicken pox (varicella) Two doses at least 4 weeks apart. |
Anyone who hasn't had chicken pox. (Immunity can be checked with a blood test, if necessary.) | Infected lesions, pneumonia, encephalitis, meningitis, and death | Appear rare |
|
| Hepatitis A Two doses at least 6 months apart. |
|
Impaired liver function, death | Appear rare | 94 to 100 effective |
| Hepatitis B Two doses 1 month apart, followed by a booster dose at least 6 months later. |
|
Impaired liver function, cirrhosis or cancer of the liver, death | Rare | 80 to 100 percent effective |
| Herpes zoster (shingles) Once. |
Everyone 60 and older with a history of chicken pox | Skin lesions, debilitating pain; most serious in the very old and people with suppressed immunity | Appear rare (based on limited data since this is a new vaccine) |
|
| Human papillomavirus (HPV) Two injections 8 weeks apart, with a booster at least 6 months later. |
|
Genital warts, cervical cancer | Appear rare (based on limited data since this is a new vaccine) | 95 to 100 percent effective (against four strains of HPV responsible for about 70 percent of cervical cancers and 90 percent of genital warts) |
| Influenza (flu) Once a year for injected (inactivated) vaccine or nasal spray (live vaccine). |
|
Pneumonia (especially in older or chronically ill people), inflammation of the heart muscle, death. | Injection: Rare Nasal spray: Nasal congestion 20 to 75 percent, headache 2 to 46 percent, vomiting 3 to 13 percent |
|
| Measles, mumps, rubella Two doses at least 4 weeks apart. |
Adults born after 1957 who were never immunized or infected. (Adults born earlier are generally immune. Immunity can be checked with a blood test, if necessary.) | Measles: Pneumonia, encephalitis, death Mumps: Meningitis, inflamed testicles or ovaries, deafness Rubella: Encephalitis, internal bleeding, eye damage, deafness, heart defects and retardation in children born to infected mothers |
Fever 5 to 15 percent, joint pain in women 25 percent, rash 5 percent, others appear rare | Measles: 99 percent effective Mumps: 90 to 97 percent effective Rubella: 95 percent effective |
| Meningococcal disease (meningitis) Once. (Booster shot after 5 years for some high-risk people.) |
|
Bloodstream infections, pneumonia, hearing loss, neurologic damage, loss of limb, death | Rare | 98 percent effective |
| Pneumococcal disease (pneumonia) Once. (Booster shot after 5 years for people who got first shot before age 65 or are at very high risk.) |
|
Pneumonia, most serious in elderly and chronically ill; death | Rare | 60 to 70 percent effective |
| Tetanus, diphtheria, pertussis Once for pertussis and 3 to 4 doses over one year, plus a booster every 10 years, for tetanus and diphtheria. |
|
Tetanus: Lockjaw, convulsions, pneumonia, death Diphtheria: Paralysis, heart failure, coma, death Pertussis: Severe coughing, impaired breathing, pneumonia, death |
Rare | Tetanus: 99 percent effective Diphtheria: 95 percent effective Pertussis: 80 to 85 percent effective |